Furthermore, JPI-547 exhibited specific immune modulation in cancer cells with HRD, likely through activation of the cGAS-STING pathway, which is associated with increased tumor immunogenicity and potential responsiveness to immune checkpoint inhibitors. The gene discussed is CGAS; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.